Soluble Microneedle Drug Delivery System - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511241596

Publication Date:

November 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

The global market for Soluble Microneedle Drug Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Soluble Microneedle Drug Delivery System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Soluble Microneedle Drug Delivery System by region & country, by Type, and by Application.
The Soluble Microneedle Drug Delivery System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soluble Microneedle Drug Delivery System.
麻豆原创 Segmentation
By Company
Corium
LG
Raphas
COSMED
Zhongke Microneedle
Excellent microorganisms
Qinglan Biology
Segment by Type:
Hydrogels
Polymer
Sugar
Segment by Application
Medicine
Vaccine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Soluble Microneedle Drug Delivery System manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Soluble Microneedle Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Soluble Microneedle Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Soluble Microneedle Drug Delivery System Product Introduction
1.2 Global Soluble Microneedle Drug Delivery System 麻豆原创 Size Forecast
1.3 Soluble Microneedle Drug Delivery System 麻豆原创 Trends & Drivers
1.3.1 Soluble Microneedle Drug Delivery System Industry Trends
1.3.2 Soluble Microneedle Drug Delivery System 麻豆原创 Drivers & Opportunity
1.3.3 Soluble Microneedle Drug Delivery System 麻豆原创 Challenges
1.3.4 Soluble Microneedle Drug Delivery System 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Soluble Microneedle Drug Delivery System Players Revenue Ranking (2023)
2.2 Global Soluble Microneedle Drug Delivery System Revenue by Company (2019-2024)
2.3 Key Companies Soluble Microneedle Drug Delivery System Manufacturing Base Distribution and Headquarters
2.4 Key Companies Soluble Microneedle Drug Delivery System Product Offered
2.5 Key Companies Time to Begin Mass Production of Soluble Microneedle Drug Delivery System
2.6 Soluble Microneedle Drug Delivery System 麻豆原创 Competitive Analysis
2.6.1 Soluble Microneedle Drug Delivery System 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Soluble Microneedle Drug Delivery System Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soluble Microneedle Drug Delivery System as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hydrogels
3.1.2 Polymer
3.1.3 Sugar
3.2 Global Soluble Microneedle Drug Delivery System Sales Value by Type
3.2.1 Global Soluble Microneedle Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Soluble Microneedle Drug Delivery System Sales Value, by Type (2019-2030)
3.2.3 Global Soluble Microneedle Drug Delivery System Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicine
4.1.2 Vaccine
4.2 Global Soluble Microneedle Drug Delivery System Sales Value by Application
4.2.1 Global Soluble Microneedle Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Soluble Microneedle Drug Delivery System Sales Value, by Application (2019-2030)
4.2.3 Global Soluble Microneedle Drug Delivery System Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Soluble Microneedle Drug Delivery System Sales Value by Region
5.1.1 Global Soluble Microneedle Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Soluble Microneedle Drug Delivery System Sales Value by Region (2019-2024)
5.1.3 Global Soluble Microneedle Drug Delivery System Sales Value by Region (2025-2030)
5.1.4 Global Soluble Microneedle Drug Delivery System Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.2.2 North America Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.3.2 Europe Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.4.2 Asia Pacific Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.5.2 South America Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.6.2 Middle East & Africa Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value
6.3 United States
6.3.1 United States Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.3.2 United States Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.4.2 Europe Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.5.2 China Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.6.2 Japan Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.7.2 South Korea Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.8.2 Southeast Asia Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.9.2 India Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Corium
7.1.1 Corium Profile
7.1.2 Corium Main Business
7.1.3 Corium Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.1.4 Corium Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.1.5 Corium Recent Developments
7.2 LG
7.2.1 LG Profile
7.2.2 LG Main Business
7.2.3 LG Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.2.4 LG Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.2.5 LG Recent Developments
7.3 Raphas
7.3.1 Raphas Profile
7.3.2 Raphas Main Business
7.3.3 Raphas Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.3.4 Raphas Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.3.5 COSMED Recent Developments
7.4 COSMED
7.4.1 COSMED Profile
7.4.2 COSMED Main Business
7.4.3 COSMED Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.4.4 COSMED Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.4.5 COSMED Recent Developments
7.5 Zhongke Microneedle
7.5.1 Zhongke Microneedle Profile
7.5.2 Zhongke Microneedle Main Business
7.5.3 Zhongke Microneedle Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.5.4 Zhongke Microneedle Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.5.5 Zhongke Microneedle Recent Developments
7.6 Excellent microorganisms
7.6.1 Excellent microorganisms Profile
7.6.2 Excellent microorganisms Main Business
7.6.3 Excellent microorganisms Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.6.4 Excellent microorganisms Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.6.5 Excellent microorganisms Recent Developments
7.7 Qinglan Biology
7.7.1 Qinglan Biology Profile
7.7.2 Qinglan Biology Main Business
7.7.3 Qinglan Biology Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.7.4 Qinglan Biology Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.7.5 Qinglan Biology Recent Developments
8 Industry Chain Analysis
8.1 Soluble Microneedle Drug Delivery System Industrial Chain
8.2 Soluble Microneedle Drug Delivery System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Soluble Microneedle Drug Delivery System Sales Model
8.5.2 Sales Channel
8.5.3 Soluble Microneedle Drug Delivery System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Corium
LG
Raphas
COSMED
Zhongke Microneedle
Excellent microorganisms
Qinglan Biology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.